cas | 910463-68-2 | quality | 99% |
MF | C187h291n45o59 | Transport Packaging | 100g/1kg |
EINECS | 203-405-2 | Specification | 2mg 5mg 10mg |
origin | china | trademark | hangyu |
color | white | Exterior | powder |
Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
The higher-dose formulation of semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m 2 ) or who are overweight (initial BMI ≥ 27 kg/m 2 ) and have at least one weight-related comorbidity .
A review of anti-obesity treatments found that semaglutide as well as tirzepatide (which has an overlapping mechanism of action) were more promising than previous anti-obesity drugs, although less effective than bariatric surgery .
There is evidence, primarily from animal studies, that semaglutide also reduces non-food cravings, such as for alcohol.